A5014302833- Respiratory viral infections research
- Influenza Virus Research Studies
- Pharmacogenetics and Drug Metabolism
- Animal Disease Management and Epidemiology
- Antioxidant Activity and Oxidative Stress
- Pancreatitis Pathology and Treatment
- Carcinogens and Genotoxicity Assessment
- Pneumonia and Respiratory Infections
- Pancreatic function and diabetes
- Diabetes Treatment and Management
- Data-Driven Disease Surveillance
Fundación para el Fomento de la Investigación Sanitaria y Biomédica de la Comunitat Valenciana
2014-2015
Influenza is a global public health problem. However, severe influenza only recently has been addressed in routine surveillance. The Global Hospital Surveillance Network (GIHSN) was established to study the epidemiology of consecutive seasons different countries. Our objective describe GIHSN approach and methods. uses prospective active surveillance identify admissions permanent residents well-defined geographic areas sites around world. A core common protocol followed. After consent, data...
The Global Influenza Hospital Surveillance Network (GIHSN) was developed to improve understanding of severe influenza infection, as represented by hospitalized cases. GIHSN is composed coordinating sites, mainly affiliated with health authorities, each which supervises and compiles data from one seven hospitals. This report describes the distribution viruses A(H1N1), A(H3N2), B/Victoria, B/Yamagata resulting in hospitalization during 2012–2013, network's first year. In included 21 hospitals...
Background The effectiveness of currently licensed vaccines against influenza has not been clearly established, especially among individuals at increased risk for complications from influenza. We used a test-negative approach to estimate vaccine (IVE) hospitalization with laboratory-confirmed based on data collected the Global Influenza Hospital Surveillance Network (GIHSN). Methods and Findings This was multi-center, prospective, active surveillance, hospital-based epidemiological study...
Abstract Aim To estimate risks of diabetic ketoacidosis (DKA), acute liver injury (ALI), kidney (AKI), chronic disease (CKD), severe complications urinary tract infection (UTI) and genital (GI) among patients with type 2 diabetes initiating empagliflozin versus those a dipeptidyl peptidase‐4 (DPP‐4) inhibitor. Materials Methods In this large multinational, observational, new‐user cohort study in UK, Danish US healthcare data sources, initiated or DPP‐4 inhibitor between August 2014 2019,...
Hepatotoxic reactions are an important identified risk listed in the agomelatine management plan. This post-authorisation safety study evaluated effectiveness of additional risk-minimisation measures (aRMMs) for agomelatine. The objective this was to evaluate, among physicians prescribing and their patients, liver function monitoring adherence, compliance with contraindications patients' reasons non-compliance monitoring. A non-interventional cohort conducted adults initiating routine...